Protein patterns and proteins that identify subtypes of glioblastoma multiforme
- PMID: 15286718
- DOI: 10.1038/sj.onc.1207770
Protein patterns and proteins that identify subtypes of glioblastoma multiforme
Abstract
Glioblastoma multiforme (GBM) has been subdivided into two types based on clinical and genetic findings: primary tumors, which arise de novo, and secondary tumors, which progress from lower grade gliomas to GBMs. To analyse this dichotomy at the protein level, we employed selective tissue microdissection to obtain pure populations of tumor cells, which we studied using two-dimensional protein gel electrophoresis (2-DGE) and protein sequencing of select target proteins. Protein patterns were analysed in a blinded manner from the clinical and genetic data. 2-DGE clearly identified two distinct populations of tumors. 2-DGE was reproducible and reliable, as multiple samples analysed from the same patient gave identical results. In addition, we isolated and sequenced 11 proteins that were uniquely expressed in either the primary or the secondary GBMs, but not both. We demonstrate that specific proteomic patterns can be reproducibly identified by two-dimensional gel electrophoresis from limited numbers of selectively procured, microdissected tumor cells and that two patterns of GBMs, primary versus secondary, previously distinguished by clinical and genetic differences, can be recognized at the protein level. Proteins that are expressed distinctively may have important implications for the diagnosis, prognosis, and treatment of patients with GBM.
Similar articles
-
Genetic pathways to primary and secondary glioblastoma.Am J Pathol. 2007 May;170(5):1445-53. doi: 10.2353/ajpath.2007.070011. Am J Pathol. 2007. PMID: 17456751 Free PMC article. Review.
-
Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme.Clin Cancer Res. 2005 May 15;11(10):3624-32. doi: 10.1158/1078-0432.CCR-04-2115. Clin Cancer Res. 2005. PMID: 15897557
-
Molecular mechanisms associated with chromosomal and microsatellite instability in sporadic glioblastoma multiforme.Oncology. 2004;66(5):395-403. doi: 10.1159/000079488. Oncology. 2004. PMID: 15331927
-
Independent molecular development of metachronous glioblastomas with extended intervening recurrence-free interval.Brain Pathol. 2003 Oct;13(4):598-607. doi: 10.1111/j.1750-3639.2003.tb00488.x. Brain Pathol. 2003. PMID: 14655763 Free PMC article.
-
Applications of emerging molecular technologies in glioblastoma multiforme.Expert Rev Neurother. 2008 Oct;8(10):1497-506. doi: 10.1586/14737175.8.10.1497. Expert Rev Neurother. 2008. PMID: 18928343 Free PMC article. Review.
Cited by
-
Genetic pathways to primary and secondary glioblastoma.Am J Pathol. 2007 May;170(5):1445-53. doi: 10.2353/ajpath.2007.070011. Am J Pathol. 2007. PMID: 17456751 Free PMC article. Review.
-
Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.J Neurosurg. 2011 Oct;115(4):789-95. doi: 10.3171/2011.5.JNS11451. Epub 2011 Jun 17. J Neurosurg. 2011. PMID: 21682567 Free PMC article.
-
Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome.Iran J Cancer Prev. 2014 Spring;7(2):87-95. Iran J Cancer Prev. 2014. PMID: 25250155 Free PMC article.
-
Recent advances in the molecular understanding of glioblastoma.J Neurooncol. 2012 May;108(1):11-27. doi: 10.1007/s11060-011-0793-0. Epub 2012 Jan 20. J Neurooncol. 2012. PMID: 22270850 Free PMC article. Review.
-
Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment.Br J Cancer. 2006 Jun 19;94(12):1853-63. doi: 10.1038/sj.bjc.6603190. Epub 2006 May 30. Br J Cancer. 2006. PMID: 16736004 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials